MHRA Class 4 Medicines Defect Notification: Enalapril maleate/ Hydrochlorothiazide 20 mg/12.5 mg Tablets (Star Pharmaceuticals Ltd)
MHRA Class 4 Medicines Defect Notification: Enalapril maleate/ Hydrochlorothiazide 20 mg/12.5 mg Tablets (Star Pharmaceuticals Ltd) Drug alert number: EL(26)A/48 Date issued: 12 November 2026 Star Pharmaceuticals Limited have informed the MHRA of a typographical error on the strength of hydrochlorothiazide printed on the front face of the carton which incorrectly states “12. mg” instead of [...]
The post MHRA Class 4 Medicines Defect Notification: Enalapril maleate/ Hydrochlorothiazide 20 mg/12.5 mg Tablets (Star Pharmaceuticals Ltd) appeared first on Community Pharmacy England.